True-T - Improving T-cell response quantification with holistic artificial intelligence based prediction in immunohistochemistry images.

01 December 2024

Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study.

01 May 2024

Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer.

10 April 2024

Timing of Radiotherapy (RT) After Radical Prostatectomy (RP): Long-term outcomes in the RADICALS-RT trial [NCT00541047].

05 April 2024

The Virtual Child.

04 April 2024

The Lancet Commission on prostate cancer: planning for the surge in cases.

04 April 2024

Digital pathology for reporting histopathology samples, including cancer screening samples - definitive evidence from a multisite study.

01 April 2024

Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate Cancer.

01 April 2024

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.

29 March 2024

Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials.

25 March 2024

Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer.

20 March 2024

FUME-TCRseq enables sensitive and accurate sequencing of the T-cell receptor from limited input of degraded RNA.

14 March 2024